KC
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Stools from a human APOEe2 donor reduces amyloid and tau pathology and increases neuroinflammation in a 3xTg AD mouse model | Frontiers in aging neuroscience | 2025 | 19 | 20 | |||
Fecal Microbiota Transplantation ( FMT ) From a Human at Low Risk for Alzheimer's Disease Improves Short‐Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model | Genes, brain and behavior | 2025 | 13 | 12 | |||
Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells | Journal of cerebral blood flow and metabolism | 2025 | 12 | 11 | |||
Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease | Neurobiology of disease | 2024 | 32 | 17 | |||
Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats | Journal of Alzheimer's disease | 2024 | 62 | 20 | |||
Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease | NeuroImage | 2024 | 75 | 10 | |||
Brain and plasmatic CLUSTERIN are translational markers of Alzheimer's disease | Brain pathology | 2024 | 54 | 16 | |||
18 kDa Translocator Protein TSPO Is a Mediator of Astrocyte Reactivity | ACS omega | 2023 | 154 | 36 | |||
Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum | Molecular brain | 2023 | 131 | 27 | |||
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases | Nature communications | 2023 | 205 | 38 | |||
Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats | Journal of neuroinflammation | 2022 | 153 | 48 | |||
Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice | Journal of Alzheimer's disease | 2022 | 302 | 1 | |||
The 18 kDa translocator protein is associated with microglia in the hippocampus of non-demented elderly subjects | Aging brain | 2022 | 140 | 68 | |||
Amyloid and Tau Induce Cell Death Independently of TSPO Polymerization and Density Changes | ACS omega | 2021 | 179 | 84 | |||
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 274 | 133 | |||
Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer's disease | Brain Communications | 2021 | 302 | 119 | |||
Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue (FACS-RTT) to Determine the Cellular Origin of Radioactive Signal | Journal of visualized experiments | 2021 | 169 | 0 | |||
Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer's Disease and Neurodegeneration: Old Drugs, New Concerns | Frontiers in oncology | 2021 | 79 | 14 | |||
Cellular sources of TSPO expression in healthy and diseased brain | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 329 | 146 | |||
Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model | Neurobiology of Aging | 2021 | 306 | 169 | |||
Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer's disease | Scientific reports | 2021 | 168 | 84 | |||
Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer's Disease | Journal of Alzheimer's Disease | 2020 | 359 | 484 | |||
Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease? | Journal of Alzheimer's Disease | 2020 | 474 | 2 | |||
In Vivo TSPO Signal and Neuroinflammation in Alzheimer's Disease | Cells | 2020 | 233 | 124 | |||
Spatial reference learning deficits in absence of dysfunctional working memory in the TgF344-AD rat model of Alzheimer's disease | Genes, Brain and Behavior | 2020 | 291 | 2 | |||
Learning from the Past: a Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease | Current Alzheimer Research | 2020 | 303 | 6 | |||
Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding | Journal of Cerebral Blood Flow and Metabolism | 2019 | 489 | 1 |